The reference genome is bracing for its next leap forward. Geneticist Ting Wang wants the process to embrace both science and social equity.
Is the current spike in highway deaths connected to more widespread cannabis use? Testing obstacles have stood in the way of knowing for sure. That may soon change.
Computer-generated nonsense studies and other fake papers find their way into the scientific literature all too often. A few crusading researchers are fighting back.
Most genetic research has focused people of European descent. Some are fighting to bring discarded data from other groups back to the table.
Large trials deliver results based on averages, not individuals. The N-of-1 model is a plucky—but labor-intensive—way to right the system.
Proton therapy has been a cutting-edge cancer therapy for decades. Can researchers at last zero in on its best applications?
Policymakers call for algorithms in health care to become more transparent. But at what cost?
New research looks into young people’s anxiety around environmental collapse.
What if drugs were released to the public earlier, then graded on their performance in the real world?
Troves of data are gathered during clinical trials, but most of it stays locked away. Could freeing it lead to new cures?
Peter L. Slavin & Thomas J. Lynch Jr. discuss the growing “open data” movement and its implications for scientific research
Top Stories
Selected Reads
For decades, a tiny encampment of researchers has held that statin treatment is a hoax. In a time when contrarian views roar to life on social media, how can medicine keep minority opinions from doing irreparable harm?
Two years in deep space will subject the body to unprecedented stresses. Scientists are probing the secrets to survival.
A freak explosion tore through the quiet Nova Scotian city, prompting one of the most dramatic medical responses in history.